116 related articles for article (PubMed ID: 38836387)
21. Sustained delivery of a camptothecin prodrug - CZ48 by nanosuspensions with improved pharmacokinetics and enhanced anticancer activity.
Dong D; Hsiao CH; Giovanella BC; Wang Y; Chow DS; Li Z
Int J Nanomedicine; 2019; 14():3799-3817. PubMed ID: 31213802
[No Abstract] [Full Text] [Related]
22. Supramolecular Crafting of Self-Assembling Camptothecin Prodrugs with Enhanced Efficacy against Primary Cancer Cells.
Su H; Zhang P; Cheetham AG; Koo JM; Lin R; Masood A; Schiapparelli P; Quiñones-Hinojosa A; Cui H
Theranostics; 2016; 6(7):1065-74. PubMed ID: 27217839
[TBL] [Abstract][Full Text] [Related]
23. Carrier-free Janus nano-prodrug based on camptothecin and gemcitabine: Reduction-triggered drug release and synergistic in vitro antiproliferative effect in multiple cancer cells.
Xu Y; Huang Y; Zhang X; Lu W; Yu J; Liu S
Int J Pharm; 2018 Oct; 550(1-2):45-56. PubMed ID: 30138703
[TBL] [Abstract][Full Text] [Related]
24. Efficient Click Synthesis of a Protonized and Reduction-Sensitive Amphiphilic Small-Molecule Prodrug Containing Camptothecin and Gemcitabine for a Drug Self-Delivery System.
Dong S; He J; Sun Y; Li D; Li L; Zhang M; Ni P
Mol Pharm; 2019 Sep; 16(9):3770-3779. PubMed ID: 31348660
[TBL] [Abstract][Full Text] [Related]
25. A prodrug nanoassembly entrapping drugs as a tumor-targeted delivery system.
Yuan Z; Yi X; Zhang J; Cheng S; Zhuo R; Li F
Chem Commun (Camb); 2013 Jan; 49(8):801-3. PubMed ID: 23235958
[TBL] [Abstract][Full Text] [Related]
26. Carbonate esters turn camptothecin-unsaturated fatty acid prodrugs into nanomedicines for cancer therapy.
Li Y; Kang T; Wu Y; Chen Y; Zhu J; Gou M
Chem Commun (Camb); 2018 Feb; 54(16):1996-1999. PubMed ID: 29411840
[TBL] [Abstract][Full Text] [Related]
27. Kinetics and mechanisms of activation of alpha-amino acid ester prodrugs of camptothecins.
Song L; Bevins R; Anderson BD
J Med Chem; 2006 Jul; 49(14):4344-55. PubMed ID: 16821794
[TBL] [Abstract][Full Text] [Related]
28. Dual Stable Nanomedicines Prepared by Cisplatin-Crosslinked Camptothecin Prodrug Micelles for Effective Drug Delivery.
Li Y; Lu H; Liang S; Xu S
ACS Appl Mater Interfaces; 2019 Jun; 11(23):20649-20659. PubMed ID: 31117440
[TBL] [Abstract][Full Text] [Related]
29. Benzyl ether-linked glucuronide derivative of 10-hydroxycamptothecin designed for selective camptothecin-based anticancer therapy.
Leu YL; Chen CS; Wu YJ; Chern JW
J Med Chem; 2008 Mar; 51(6):1740-6. PubMed ID: 18318465
[TBL] [Abstract][Full Text] [Related]
30. Synthesis of Gemcitabine-Threonine Amide Prodrug Effective on Pancreatic Cancer Cells with Improved Pharmacokinetic Properties.
Hong S; Fang Z; Jung HY; Yoon JH; Hong SS; Maeng HJ
Molecules; 2018 Oct; 23(10):. PubMed ID: 30314360
[TBL] [Abstract][Full Text] [Related]
31. Mitochondria-Specific Anticancer Drug Delivery Based on Reduction-Activated Polyprodrug for Enhancing the Therapeutic Effect of Breast Cancer Chemotherapy.
Wang Y; Zhang T; Hou C; Zu M; Lu Y; Ma X; Jia D; Xue P; Kang Y; Xu Z
ACS Appl Mater Interfaces; 2019 Aug; 11(32):29330-29340. PubMed ID: 31329411
[TBL] [Abstract][Full Text] [Related]
32. Antitumor potential of a novel camptothecin derivative, ZBH-ZM-06.
Wu D; Zhao DW; Li YQ; Shi WG; Yin QL; Tu ZK; Yu YY; Zhong BH; Yu H; Bao WG
Oncol Rep; 2018 Feb; 39(2):871-879. PubMed ID: 29251321
[TBL] [Abstract][Full Text] [Related]
33. Evaluation the synergistic antitumor effect of methotrexate-camptothecin codelivery prodrug from self-assembly process to acid-catalyzed both drugs release: A comprehensive theoretical study.
Pakdel M; Raissi H; Hosseini ST
J Comput Chem; 2020 Jun; 41(16):1486-1496. PubMed ID: 32190916
[TBL] [Abstract][Full Text] [Related]
34. Fabrication of Hyperbranched Block-Statistical Copolymer-Based Prodrug with Dual Sensitivities for Controlled Release.
Zheng L; Wang Y; Zhang X; Ma L; Wang B; Ji X; Wei H
Bioconjug Chem; 2018 Jan; 29(1):190-202. PubMed ID: 29216714
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and Antitumor Properties of BQC-Glucuronide, a Camptothecin Prodrug for Selective Tumor Activation.
Prijovich ZM; Burnouf PA; Chou HC; Huang PT; Chen KC; Cheng TL; Leu YL; Roffler SR
Mol Pharm; 2016 Apr; 13(4):1242-50. PubMed ID: 26824303
[TBL] [Abstract][Full Text] [Related]
36. Acidity-responsive shell-sheddable camptothecin-based nanofibers for carrier-free cancer drug delivery.
Zhou Z; Piao Y; Hao L; Wang G; Zhou Z; Shen Y
Nanoscale; 2019 Aug; 11(34):15907-15916. PubMed ID: 31414111
[TBL] [Abstract][Full Text] [Related]
37. GSH/pH dual-responsive biodegradable camptothecin polymeric prodrugs combined with doxorubicin for synergistic anticancer efficiency.
Li J; Hu ZE; Yang XL; Wu WX; Xing X; Gu B; Liu YH; Wang N; Yu XQ
Biomater Sci; 2019 Aug; 7(8):3277-3286. PubMed ID: 31180396
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of Nitrobenzyl Derivatives of Camptothecin as Anti-Cancer Agents and Potential Hypoxia Targeting Prodrugs.
Liang D; Wu X; Hasinoff BB; Herbert DE; Tranmer GK
Molecules; 2018 Aug; 23(8):. PubMed ID: 30111719
[TBL] [Abstract][Full Text] [Related]
39. Rapidly cell-penetrating and reductive milieu-responsive nanoaggregates assembled from an amphiphilic folate-camptothecin prodrug for enhanced drug delivery and controlled release.
Xu Z; Hou M; Shi X; Gao YE; Xue P; Liu S; Kang Y
Biomater Sci; 2017 Feb; 5(3):444-454. PubMed ID: 28058423
[TBL] [Abstract][Full Text] [Related]
40. Linker-determined drug release mechanism of free camptothecin from self-assembling drug amphiphiles.
Cheetham AG; Ou YC; Zhang P; Cui H
Chem Commun (Camb); 2014 Jun; 50(45):6039-42. PubMed ID: 24769796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]